Tag: Cordis-X

Cordis-X Makes Strategic Investment in Adient Medical, Developer of First Fully Absorbable Inferior Vena Cava (IVC) Filter

Coronary/Structural Heart by 0 comments

Signals continued investment in accelerated cardiovascular technology development MENLO PARK, Calif., June 14, 2022 /PRNewswire/ — Cordis-X today announced an $11.5 million Series F investment in Adient Medical, maker of a next-generation absorbable inferior vena cava (IVC) filter that provides protection against pulmonary embolisms (PE). The device is designed to avoid well-documented risks of perforation, migration, fracture, […]

Continue Reading →

DR. JEREMY DURACK AND DR. JOHN SIMPSON TO JOIN CORDIS-X INNOVATION ACCELERATOR

Financial by 0 comments

MENLO PARK, Calif., Jan. 18, 2022 /PRNewswire/ — Ajax Health has announced the appointments of two of the most respected cardiovascular professionals to Cordis-X, an independent accelerator created to drive innovation and growth to Cordis. Cordis is a storied medical device brand with global reach that was acquired from Cardinal Health last […]

Continue Reading →